Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 10,357 | 3,307 | 0 | 0 | 29 |
| Cost of Goods | 143 | 91 | N/A | N/A | N/A |
| Gross Profit | 10,214 | 3,216 | N/A | N/A | 29 |
| Operating Expenses | 51,853 | 39,579 | 32,332 | 27,437 | 20,279 |
| Operating Income | -41,496 | -36,272 | -32,332 | -27,437 | -20,250 |
| Interest Expense | 4,515 | 1,776 | 25 | 25 | 0 |
| Other Income | 0 | 0 | 3 | 1,496 | 84 |
| Pre-tax Income | -46,011 | -38,048 | -32,354 | -25,966 | -20,166 |
| Net Income Continuous | -46,011 | -38,048 | -32,354 | -25,966 | -20,166 |
| Net Income | $-46,011 | $-38,048 | $-32,354 | $-25,966 | $-20,166 |
| EPS Basic Total Ops | -0.46 | -0.41 | -0.39 | -0.38 | -0.38 |
| EPS Basic Continuous Ops | -0.46 | -0.41 | -0.39 | -0.38 | -0.38 |
| EPS Diluted Total Ops | -0.46 | -0.41 | -0.39 | -0.38 | -0.38 |
| EPS Diluted Continuous Ops | -0.46 | -0.41 | -0.39 | -0.38 | -0.38 |
| EBITDA(a) | $-41,387 | $-36,228 | $-32,329 | $-27,431 | $-20,240 |